Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01967069 · ClinicalTrials.gov registry record · Phase 3
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
A Phase 3 study, sponsored by Primus Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 277
- Enrollment target
NCT01967069 is a Phase 3 study that has completed, run by Primus Pharmaceuticals. The registered enrollment target is 277 participants.
The verdict
NCT01967069, a Phase 3 study, has completed, sponsored by Primus Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 277 participants
- Enrollment target
Study Summary
The objectives of this study are to compare the efficacy and safety of DFD01 Spray to Vehicle Spray for topical treatment of moderate plaque psoriasis
Interventions
- DRUG DFD01 Spray
- DRUG Vehicle Spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01967069
The ClinicalTrials.gov registry entry for NCT01967069 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 277 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Primus Pharmaceuticals, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DFD01 Spray is the first listed.
NCT01967069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01967069 about?
NCT01967069 is a clinical study titled "A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis". The objectives of this study are to compare the efficacy and safety of DFD01 Spray to Vehicle Spray for topical treatment of moderate plaque psoriasis
What is the current status of trial NCT01967069?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 277 participants. The study started on 2013-11. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01967069?
The interventions under investigation include: DFD01 Spray (DRUG), Vehicle Spray (DRUG).
Who is sponsoring clinical trial NCT01967069?
This trial is sponsored by Primus Pharmaceuticals, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.